U.S. FDA Approves CARVYKTI™ (ciltacabtagene autoleucel), Janssen's First Cell Therapy, a ...

Retrieved on: 2022-03-01 02:58:30

Tags for this article:

Click the tags to see associated articles and topics

U.S. FDA Approves CARVYKTI™ (ciltacabtagene autoleucel), Janssen's First Cell Therapy, a .... View article details on hiswai:

Excerpt

... an immunomodulatory agent, and an anti-CD38 monoclonal antibody.1 The approval is based on data from the pivotal CARTITUDE-1 study, ...

Article found on: www.biospace.com